The prognostic role of SLC1A5 also was assessed in stomach adenocarcinoma and its association with tumor-infiltrating immune cells and immune checkpoints in the tumor microenvironment (TME) was revealed [51]. This evidence concerns the gene SLC1A5 and neoplasm.